首页 | 本学科首页   官方微博 | 高级检索  
     

糖皮质激素辅助治疗儿童重症肺炎支原体肺炎的临床研究
引用本文:孙建华,赵雨芳,叶君红. 糖皮质激素辅助治疗儿童重症肺炎支原体肺炎的临床研究[J]. 中国临床药理学杂志, 2021, 0(7): 795-797,801
作者姓名:孙建华  赵雨芳  叶君红
作者单位:湖州市中医院儿科;金华市中心医院儿科;长兴县妇保院儿科
摘    要:目的 观察糖皮质激素的合理使用对儿童重症肺炎支原体肺炎(SMPP)的辅助治疗效果.方法 将80例患儿依据随机数表法分为对照组40例与试验组40例.对照组用阿奇霉素序贯治疗:第1~7天,10 mg·kg-1阿奇霉素注射液+葡萄糖注射液250 mL,每天1次,静脉滴注;第8~15天,10 mg·kg-1阿奇霉素分散片,每天...

关 键 词:糖皮质激素  肺炎支原体肺炎  阿奇霉素  甲泼尼龙

Clinical trial of glucocorticoid on adjuvant therapy of severe mycoplasma pneumoniae pneumonia in children
SUN Jian-hua,ZHAO Yu-fang,YE Jun-hong. Clinical trial of glucocorticoid on adjuvant therapy of severe mycoplasma pneumoniae pneumonia in children[J]. The Chinese Journal of Clinical Pharmacology, 2021, 0(7): 795-797,801
Authors:SUN Jian-hua  ZHAO Yu-fang  YE Jun-hong
Affiliation:(Department of Pediatrics,Huzhou Hospital of Traditional Chinese Medicine,Huzhou 313000,Zhejiang Province,China;Department of Pediatrics,Jinhua Central Hospital,Jinhua 321000,Zhejiang Province,China;Department of Pediatrics,Changxing County Women’s Hospital,Huzhou 313000,Zhejiang Province,China)
Abstract:Objective To observe the effect of the rational use of corticosteroids on the adjuvant treatment of severe mycoplasma pneumoniae pneumonia(SMPP)in children.Methods According to the random number method,80 children were divided into control group(n=40)and an treatment group(n=40).Control group was treated with azithromycin sequentially:d1-d7,10 mg·kg-1 azithromycin injection+glucose injection 250 mL,qd,intravenous drip;on d8-d15,10 mg·kg-1 azithromycin dispersible tablets,qd,orally.Treatment group was treated with glucocorticoids on the basis of control group:d1-d3,1.5 mg·kg-1 methylprednisolone sodium succinate,qd,intravenous drip;on d4-d15,1.0 mg·kg-1 methylprednisolone sodium succinate,qd,intravenous drip.The treatment time for both groups was 15 d.The hypersensitivity C-reactive protein(hs-CRP),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),duration of symptoms and signs,treatment effects,and adverse drug reactions in two gorups were compared.Results After treatment,the total effective rates in treatment group and control group were 100.00%(40 cases/40 cases)and 85.00%(34 cases/40 cases),the difference was statistically significant(P<0.05).After treatment,the hs-CRP in treatment group and control group were(9.87±2.72)and(12.25±3.81)mg·L-1,IL-6 were(5.13±0.72)and(6.62±0.81)pg·mL-1,TNF-αwere(4.20±1.32)and(4.71±1.77)ng·L-1,all with significant differences(all P<0.05).The duration of fever in treatment group and control group were(2.01±0.47)and(3.34±0.62)d,the duration of cough were(3.20±0.61)and(5.24±1.22)d,the duration of rales in lungs were(5.37±1.72)and(7.53±1.91)d,the difference were all statistically significant(all P<0.05).The incidence of adverse drug reactions in treatment group and control group were 20.00%and 17.50%,without significant difference(P>0.05).Conclusion Reasonable use of glucocorticoids in the treatment of SMPP children help to improve the treatment effect,improve serum factor indicators,shorten the duration of symptoms and signs.
Keywords:glucocorticoids  mycoplasma pneumoniae pneumonia  azithromycin  methylprednisolone
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号